Budesonide
NDC 0591-2510, Budesonide, tablet, film coated, extended release, from Actavis Pharma, Inc..
- Product NDC
- 0591-2510
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205457
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2510 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUDESONIDE9 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-2510-30 | 00591251030 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0591-2510-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/41d4fd39-81ee-41be-b34d-efb12b3a359dNADAC price for package 00591251030
GET /v1/drugs/nadac/00591251030
Use it
Look up 0591-2510 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2510 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-2510. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.